ATR promotes cilia signalling: links to developmental impacts by Stiff, Tom et al.
OR I G INA L ART I C L E
ATR promotes cilia signalling: links to developmental
impacts
Tom Stiff1,†, Teresa Casar Tena3,†, Mark O’Driscoll2,*, Penny A. Jeggo1,*
and Melanie Philipp3,*
1Double Strand Break Repair Laboratory and, 2Human DNADamage Response Disorders Group, Genome Damage
and Stability Centre, University of Sussex, Brighton BN1 9RQ, UK and 3Institute for Biochemistry and Molecular
Biology, Ulm University, 89081 Ulm, Germany
*To whom correspondence should be addressed. Tel: +44 1273 678515; Fax: +44 1273 678121; Email: m.0-driscoll@sussex.ac.uk.(M.O’D.); Tel: +44 1273 678482;
Fax: +44 1273 678121; Email: p.a.jeggo@sussex.ac.uk (P.A.J.); Tel: +49 73150023287; Fax: +49 73150023277; Email: melanie.philipp@uni-ulm.de (M.P.)
Abstract
Mutations in ATR (ataxia telangiectasia and RAD3-related) cause Seckel syndrome (ATR-SS), a microcephalic primordial
dwarﬁsm disorder. Hitherto, the clinical manifestation of ATR deﬁciency has been attributed to its canonical role in DNA
damage response signalling following replication fork stalling/collapse. Here, we show that ATR regulates cilia-dependent
signalling in amanner that can be uncoupled from its function during replication. ATR-depleted or patient-derivedATR-SS cells
form cilia of slightly reduced length but are dramatically impaired in cilia-dependent signalling functions, including growth
factor and Sonic hedgehog signalling. To better understand the developmental impact of ATR loss of function, we also used
zebraﬁsh as a model. Zebraﬁsh embryos depleted of Atr resembled ATR-SS morphology, showed a modest but statistically
signiﬁcant reduction in cilia length and other morphological features indicative of cilia dysfunction. Additionally, they
displayed defects in left-right asymmetry including ambiguous expression of southpaw, incorrectly looped hearts and
randomized localization of internal organs including the pancreas, features typically conferred by cilia dysfunction. Our
ﬁndings reveal a novel role for ATR in cilia signalling distinct from its canonical function during replication and strengthen
emerging links between cilia function and development.
Introduction
Ataxia telangiectasia and RAD3-related protein (ATR) was the
ﬁrst identiﬁed causal defect for Seckel syndrome (SS) (SCKL1,
MIM no. 210600), a disorder characterized by microcephaly and
growth delay (1,2). ATR is the central kinase that activates DNA
damage response (DDR) signalling following replication stalling
or genotoxic damage (3). ATR is activated by single-stranded re-
gions of DNA that form during replication stalling/collapse and
promotes cell cycle checkpoint arrest as well as a plethora of re-
sponses that enhance recovery from replication damage. As DNA
damage is encounteredduringmost cycles of replication, ATR is es-
sential (4–6). Patient-derived ATR-deﬁcient SS cell lines (ATR-SS)
show an impaired response to replication damage, and studies
generally attribute ATR’s developmental role to this function (2,6).
In contrast to ATR, many other characterized genetic defects
for SS aswell as those for related disorders conferringmicroceph-
alic primordial dwarﬁsm (MPD) are found in centrosomal pro-
teins or those that cause centrosomal defects (7). For example,
microcephalic osteodysplastic primordial (MOPD)-type II, an
MPD disorder, is caused by mutations in PCNT, which encodes
the centrosomal protein, pericentrin (PCNT) (8,9). Additionally,
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defects in CEP152 and CENPJ also cause SS or primarymicroceph-
aly (MCPH), in which the clinical manifestation predominantly
affects head size with less or no signiﬁcant impact upon growth
(7,10–12). Indeed, causal genetic defects for MCPH, such as
MCPH1, CENPJ/CPAP, CEP213/CDK5RAP2, ASPM, WDR62, CEP135,
CEP63 and STIL, encode centrosome or spindle-associated pro-
teins, providing a further link betweenmicrocephaly and centro-
somal-spindle function (11,12). A proposed role for centrosomes
is to regulate the symmetry of cell division, which is important
during neurogenesis (11). However, the centrosome is also the
basal body from which cilia are formed (13), providing an add-
itional factor to consider for the basis underlying MPD disorders.
Indeed, deﬁciency of PCNT also causes defects in cilia formation
and function (14–16). Further, a recent study identiﬁed defects
in PLK4, a protein required for centriole biogenesis, in additional
patients with MPD (17).
Cilia are antenna-like structures that emanate from a modi-
ﬁed centriole (18,19). Previously, they have been divided into pri-
mary cilia, which are mechano- and chemosensory organelles
and motile cilia, which induce a ﬂuid ﬂow and promote motility.
However,motile cilia retain someability to sense aswell as trans-
duce molecular cues (20,21). Cilia function to transmit and
receive extracellular signals and are required for signalling path-
ways including sonic hedgehog (Shh) and Wnt signalling (22,23).
Shh signalling is important during development, including neur-
onal embryogenesis (24–26).
Defects in primary cilia formation or function underlie a range
of developmental disorders collectively termed ‘ciliopathies’ (19).
Ciliopathies are clinically heterogeneous disorders with features
that include respiratory complications, renal abnormalities, ret-
inal degeneration, structural heart defects and growth retard-
ation. Abnormalities in neuronal development have also been
reported in ciliopathies (19). Indeed, mounting evidence suggests
that cilia function is required for normal neuronal development
and/or growth. For example, mutations in POC1A and PLK4,
which encode proteins involved in centriole function, impact
upon ciliogenesis and cause primordial dwarﬁsm (17,27). Signiﬁ-
cantly, we recently reported that defects in the origin licensing
proteins, which causeMeier-Gorlin syndrome (MGS), dramatically
impede ciliogenesis and cilia signalling (16).
Zebraﬁsh have been particularly useful for characterizing the
developmental impact of deﬁciencies in cilia formation/signal-
ling (28,29). Such studies have revealed a role for cilia in left-
right patterning (30–34). In zebraﬁsh, primary as well as motile
cilia can be readily visualized and analysed for their signalling
capacity. Cilia of the left-right organizer perpetuate a counter-
clockwise ﬂow and elicit calcium spikes (35). Readouts for cilia
function include the level of nodal ﬂow, left-sided expression of
nodal-related genes and cardiac looping, a measure for oriented
organ morphogenesis (30,32–34).
We previously observed that ATR-SS cells display amodestly
elevated frequency of supernumerary centrosomes, a pheno-
type shared with PCNT-deﬁcient MOPD-type II cells and ORC-
deﬁcient MGS cells (8,16,36). Given that cilia develop from
centrosomes/centrioles and the strong relationship between
centrosome function and MPD, we examined whether ATR is
also required for cilia formation and function. Strikingly, we
show that ATR is largely dispensable for cilia formation, but
has a signiﬁcant role in promoting cilia-dependent signalling.
Furthermore, we show that ATR deﬁciency in zebraﬁsh causes
an abnormality in cilia similar to that seen in human cells,
but profoundly confers patterning defects reﬂective of ciliary
dysfunction. This represents a novel and previously uncharac-
terized role for ATR. Finally, we provide evidence that this
function of ATR is distinct to its role in promoting recovery
from replication fork stalling.
Results
ATR-SS cells display subtle centrosome and cilia
abnormalities
We previously reported that ATR-SS patient cells harbour ele-
vated supernumerary centrosomes (36). However, in this previ-
ous study, nocodazole, which has been reported to enhance
centrosome abnormalities, was added to promote accumulation
of mitotic cells. Here, we examined centrosome numbers in the
absence of nocodazole in ﬁbroblasts derived from a control and
an ATR-SS patient (Fig. 1A). Fibroblasts from patients with muta-
tions inPCNT (PCNT)were includedas acontrolwith impaired cilia
function. A-T was included as a line with a distinct defect in DDR
signalling, to substantiate the speciﬁcityof theﬁndings for ATR. A-
T and ATR-SS cells have a similar growth rate (data not shown),
suggesting that any differences obtained cannot be attributed to
differences in proliferation. Control and A-T ﬁbroblasts showed
<1% cells with more than two centrosomes. In contrast, ATR-SS,
and more markedly, PCNT-deﬁcient MOPD-II ﬁbroblasts, dis-
played an increased frequency of supernumerary centrosomes.
Cilia formation was examined 48 h after serum starvation in
patient ﬁbroblasts. Control, ATR-SS, A-T and PCNT-patient ﬁbro-
blasts form cilia efﬁciently under this condition (Fig. 1B). Cilia
also formed efﬁciently following siRNA-mediated depletion of
ATR (ATR siRNA). In contrast, PCNT siRNA ablated cilia formation
(Fig. 1B and C), consistent with ﬁndings that PCNT is required
for cilia formation, but PCNT-patient cells are hypomorphic
(14–16,37). Quantitative assessment of cilia length in ATR-SS
cells revealed a modest but statistically signiﬁcant reduction
when compared with control cells (Fig. 1D) (P < 0.01, Mann–
Whitney rank-sum test). ATR-SS cells efﬁciently exited the cell
cycle following serum starvation (Fig. 1E).
Cilia-dependent response to PDGF is impaired in
ATR-SS cells
We examined whether ATR deﬁciency affects cilia function. We
previously observed that S phase entry following cell cycle exit
and re-entry (after serum addition) was delayed in two Sensen-
brenner syndrome cells (deﬁcient in IFT43 or WDR35), which
have impaired intraﬂagellar transport and cilia function, and in
ORC1-deﬁcient cells, which show very delayed cilia formation
(16). We proposed that cilia-dependent signalling promotes cell
cycle re-entry following serum starvation. To examine ATR de-
pendency, we monitored S phase entry by bromodeoxyuridine
(BrdU) labelling following cell cycle exit (48 h in low serum) and
subsequent serum addition. Strikingly, both ATR-SS and PCNT
ﬁbroblasts showed delayed S phase entry when compared with
control and A-T ﬁbroblasts (Fig. 2A). The overlapping cellular
phenotype caused by IFT43,WDR35, PCNTorATRdeﬁciency is con-
sistent with the notion that ATR lossmay impair cilia function (16).
Platelet-derived growth factor (PDGF) signalling promotes cell
cycle entry fromG0 (38). Two PDGF ligand isoforms and their cog-
nate receptors have been identiﬁed: the PDGF receptor α (PDGFR
α) speciﬁcally localizes to primary cilia, is upregulated in serum-
starved cells and responds to the PDGF-AA ligand isoform (39)
and the PDGFRβ responds to the PDGF-BB isoform and localizes
predominantly on the plasma membrane. The response to
PDGF-AA represents a cilia-dependent pathway promoting cell
cycle entry (16). We exploited PDGF-AA and -BB isoforms to
2 | Human Molecular Genetics
 at Sussex Language Institute on M
arch 4, 2016
http://hm
g.oxfordjournals.org/
D
ow
nloaded from
 
examine cilia function as it allowsparallelmembrane-dependent
versus cilia-dependent signalling assessment. Following serum
starvation for 48 h, cells were treated with PDGF-AA or -BB iso-
forms for 11 or 24 h (Fig. 2B). BrdU was added and cell cycle re-
entry monitored by immunoﬂuorescence (IF) as the percentage
of BrdU+ cells. Control and A-T ﬁbroblasts showed a similar
ratio of BrdU+ cells when exposed to PDGF-AA or -BB; both ATR-
SS and PCNT-deﬁcient ﬁbroblasts showed substantially dimin-
ished BrdU+ cells following PDGF-AA addition (Fig. 2B).
ATR-deﬁcient patient cells show impaired Shh signalling
Cilia are enriched for actively signalling receptors. They thus co-
ordinate and transduce signals required during development
such as the Shh pathway (19,24–26). Cellular responses to se-
creted Shh are mediated by two trans-membrane proteins:
patched receptor (PTCH-1) and smoothened (SMO). Shh binds to
PTCH-1, alleviating suppression of SMO. SMO activation triggers
GLI2 nuclear localization promoting transcriptional upregulation
of Shh-pathway response genes, including GLI1, PTCH1 and HHIP.
Using quantitative reverse transcriptase–polymerase chain reac-
tion (RT–PCR), we assessed the transcriptional activation of GLI1,
using SMO as an internal control. Following SAG addition, an
SMO-binding Shh pathway agonist, control cells showed an ap-
proximately 10-fold increase in GLI1, but not SMO transcript le-
vels (Fig. 2C and D). A similar, slightly lower impact (∼8-fold)
was observed in A-T ﬁbroblasts. In contrast, GLI1 transcript levels
barely increased in either ATR or PCNT-deﬁcient ﬁbroblasts
(Fig. 2C and D). This strongly suggests that ATR-deﬁcient
ﬁbroblasts are impaired in Shh signalling, which we attribute to
their abnormal cilia function.
ATR is required for normal cilia formation and function in
zebraﬁsh
To evaluate the developmental impact of ATR’s role in cilia sig-
nalling, we chose zebraﬁsh following injection with antisense
morpholino oligonucleotides (MOs) as assays tomonitor cilia for-
mation and function have beenwell described in this system (40).
First, we assessed cilia formation following Atr depletion.We de-
pletedAtr using a previously publishedAtr-speciﬁc antisenseMO
(Atr MO) (41) and labelled cilia within the Kupffer’s vesicle (KV)
through staining of acetylated tubulin. The KV consists of a lim-
ited number of monociliated cells and functions as a temporal
left-right organizer. Following Atr depletion, we observed that
the KV area appeared slightly smaller (Fig. 3B) and the cilia mod-
estly shorter (Fig. 3A). Quantiﬁcation of cilia and KV parameters
revealed that cilia formed normally and their numbers, although
slightly diminished, were not signiﬁcantly different from control
MO-injected embryos (Fig. 3C). Strikingly, consistentwith the vis-
ual images, quantitative assessment of cilia length revealed a
small but highly signiﬁcant shortening of cilia following Atr de-
pletion (Fig. 3D). Quantiﬁcation of the KV area substantiated
this visual observation (Fig. 3E). As the cilia number was not sig-
niﬁcantly changed and because hitherto there has not been any
obvious correlation between cilia length and KV area, we suggest
that the smaller KV area in Atr MO embryos reﬂects the overall
smaller embryos.
Figure 1. ATR-SS cells show supernumerary centrosome and shortened cilia. (A) Exponentially growing hTERT ﬁbroblasts from a control (1BR3) (C), an ATR-SS patient
(ATR), a PCNT-MOPD type-II patient (PCNT) or an A-T patient (A-T) were analysed for centrosome numbers following staining with anti-γ-tubulin. Cells with more
than two centrosomes were scored. (B) Patient hTERT ﬁbroblasts [as in (A)] or 1BR3 hTERT cells subjected to PCNT or ATR siRNA were serum-starved for 48 h (0%) or
maintained in serum (10%) and processed to identify cilia using anti-acetylated tubulin and anti-γ-tubulin antibodies, which mark the entire cilia or basal body,
respectively. (C) Typical cells lacking cilia following siRNA PCNT. The arrow shows PCNT staining (i.e. no siRNA-mediated knockdown) and a cilium; asterisks denote
cells with no PCNT or cilia. (D) Cilia forming in ATR-SS cells are slightly shorter than those in control cells. This is evident visually (left panel) and following
quantiﬁcation of length (right panel). P < 0.01, Mann–Whitney rank-sum test. (E) Control cells exit the cell cycle 24 h after serum starvation. Similar kinetics of cell
cycle exit were observed in ATR-SS and PCNT cells (data not shown). Cell cycle markers were: G1, P-Rb+; S phase, BrdU+; G2, CENPF-positive; mitosis, P-H3+. All results
represent the mean ± SD of three experiments.
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Intrigued by this result, we examined whether primary cilia
were similarly affected by Atr loss. Analysis of Hedgehog
pathway activity by qPCR revealed lower levels of gli1 in Atr
MO-injected embryoswhen comparedwith Ctrl MO-injected em-
bryos (Fig. 3F). Moreover, Atr depletion signiﬁcantly increased
puma and p21 levels (Fig. 3G and H), which have been reported
to be negatively regulated by the Hedgehog pathway (42). Finally,
comparison with a well-characterized mutant for Smoothened
(smuhu1640) (43) revealed a similar reduction in the length of cilia
(Fig. 3I and J). Together these ﬁndings demonstrate that the im-
pact of Atr on cilia size is evolutionarily conserved, being
observed in zebraﬁsh as well as in human cells.
Morphological changes caused by Atr depletion in
zebraﬁsh
To assess whether Atr depletion causes an SS-like phenotype in
zebraﬁsh, we examined head and eye size of Atr MO-injected
embryos. Following injection with the previously characterized
Atr MO or a second MO interfering with splicing of atr pre-
mRNA (Atr splMO), we observed that a large percentage of
embryos had an underdeveloped head (Fig. 4A and B). SS is fur-
thermore characterized by a reduction of anterior neural struc-
tures and consistent with that, we observed smaller eyes in
embryos depleted of Atr (Fig. 4C). As the phenotype obtained
with the splice blocking MOwasmilder than that with the trans-
lation blocking MO, we assessed its ability to interfere with spli-
cing. RT–PCR demonstrated that splicing of exon 3 was only
partially inhibited when compared with the greater impact con-
ferred by the translation blocking MO (Fig. 4D). Atr loss-of-
function embryos also appeared smaller than control embryos,
consistent with the characteristic primordial dwarﬁsm (intra-
uterine and postnatal) of the patients (16).
To substantiate that these observations are a consequence of
Atr deﬁciency, we exploited a recently generated small molecule
inhibitor of Atr, ATR kinase inhibitor III (ATRi-1). To avoid
Figure 2. ATR-SS cells show impaired cilia-dependent growth-factor signalling. (A) Patient-derived hTERT ﬁbroblasts were serum-depleted for 48 h. Following serum and
BrdU addition, the percentage of BrdU+ S phase cells was monitored as indicated. At least 200 cells were monitored. (B) The indicated hTERT ﬁbroblasts were serum-
depleted for 48 h. PDGF-AA or -BB and BrdU were then added and the percentage of BrdU+ cells (i.e. cells that have entered S phase) estimated by IF 11 and 24 h later.
Results are expressed as the ratio of BrdU+ cells following treatment with PDGF-AA versus PDGF-BB. A ratio of 1 demonstrates equal signalling from PDGF ligand
isoforms (-AA or -BB) and <1 demonstrates an impaired response to PDGF-AA. The percentage of BrdU+ cells after PDGF-BB treatment after all siRNA treatments is
shown in Supplementary Material, Figure S1. This veriﬁes that the indicated siRNA does not impact upon PDGF-BB signalling. Results represent the mean ± SD of
three experiments. (C and D) qRT–PCR analysis of SMO and GLI1 transcript levels in the indicated cells with or without SAG at 24 h. SMO is a reference as it does not
change after SAG addition. The WT and PCNT data are part of a previously published data set (16). The analysis of ATR- and A-T-deﬁcient cells was carried in the
same experiments and has not been previously published. Results represent the mean ± SD of three experiments.
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interference with gastrulation movements and to selectively
target KV cilia, zebraﬁsh embryos were treated with ATRi-1
from the tailbud stage on, when the KV starts to form. Notably,
this recreated the same phenotypes as Atr MO (Fig. 4E), namely,
increased frequency of pinheads and small eyes (Fig. 4F and G).
Given the abnormal cilia length observed in the zebraﬁsh, we
also examined whether Atr knockdown creates known morpho-
logical changes associated with cilia dysfunction. We observed a
higher frequencyof pericardiac oedema, a feature often observed in
zebraﬁsh with impaired cilia (Supplementary Material, Fig. S2A–C)
(44,45).Additionally, embryosdepleted for functionalAtrdeveloped
an increased body curvature (Supplementary Material, Fig. S2D–F),
a further feature conferred by cilia dysfunction (46).
Collectively, theseﬁndingsshowthatdepletionofAtror inhibition
of Atr activity in zebraﬁsh causes a marked impact on the devel-
opment of anterior or neural structures, similar to the phenotype
observed in humans. Additionally, Atr-depleted zebraﬁsh show
some morphological features typical of cilia dysfunction.
Atr depletion causes left-right patterning defects in
zebraﬁsh
To gain further insight into the consequence of Atr depletion in
zebraﬁsh, we next examined aspects of left-right patterning,
which are frequently abnormal when cilia are dysfunctional.
First, we assessed the expression pattern of southpaw (spaw), a
nodal-related gene, which is expressed selectively in the left
lateral plate mesoderm (47). When cilia function is impaired,
spaw expression becomes randomized resulting in embryos
that display right-sided or ambiguous expression (Fig. 5A).
Although both uninjected and control-injected wild-type em-
bryos predominantly expressed spaw on the left side, we counted
a signiﬁcant number of embryos with an aberrant spaw expres-
sion domain following Atr depletion using the translation block-
ing MO (Atr MO) (Fig. 5A and B) and the splice blocking MO (Atr
splMO) (Supplementary Material, Fig. S3B). Rescue experiments
showed further that the kinase activity of ATR is required to
mediate proper cilia function as co-injection of wild-type ATR
mRNA could partially rescue the lateralization defect in contrast
to RNA encoding kinase-dead Atr (Supplementary Material,
Fig. S3A). Finally, inhibition of Atr activity also randomized the
expression of this laterality gene (Fig. 5C).
Next, we analysed heart looping after Atr depletion. Under
normal conditions, zebraﬁsh hearts undergo looping to allow
the ventricle to lie left from the atrium (D-loop). Inversely looped
hearts (L-loop) or hearts that fail to loop (N-loops) are commonly
associated with disturbed cilia formation or function. We thus
used whole-mount in situ hybridization (WMISH) against cardiac
myosin light chain 2 (cmlc2) (Fig. 5D) to visualize heart loops after
Atr depletion (Atr MO and Atr splMO, respectively) or inhibition
(ATRi-1). Similar to the results obtained for spaw, we observed a
reduction of correctly looped hearts (D-loops) at the gain of
irregularly looping hearts when embryos lacked functional Atr,
Figure 3. Atr depletion confers shorter cilia in zebraﬁsh. (A) Representative
images of cilia in the KV of zebraﬁsh embryos. Cilia were stained with an
antibody against acetylated tubulin. Outlines of the KV were visualized by
counterstaining with an antibody against atypical PKC (PKCζ). Scale bars: 5 µm.
(B) Overlay of KV outlines of CTRL MO- or Atr MO-injected embryos [eight
somite stage (ss)]. Depletion of Atr results in slightly smaller KVs. (C) Cilia
number was not signiﬁcantly altered upon Atr depletion. Three independent
experiments with 31 embryos per condition. P = 0.0770, Student’s t-test. (D) KV
cilia were short in embryos depleted for Atr. n = 7. About 10–831 cilia from 29 to
31 embryos. P < 0.0001, Student’s t-test. (E) KV area measurements of CTRL- and
Atr MO-injected embryos at eight ss. Three independent experiments with 31
embryos in total. P = 0.0166, Student’s t-test. (F) gli1 expression at 24 hpf after
injection of either CTRL MO or Atr MO. Four independent experiments.
P = 0.0008, Student’s t-test. (G) Relative expression of puma in injected embryos
(24 hpf ). n = 4, P < 0.0001, Student’s t-test. (H) p21 expression in 24 hpf embryos
summarizing four independent experiments. P < 0.0001, Student’s t-test. (I)
Representative images of KV cilia in a zebraﬁsh mutant for Smo (smuhi1640).
Scale bars: 5 µm. (J) Average cilia length in smuhi1640 mutants and wild-type
littermates. n = 1094–1826 cilia from 20 to 27 singly genotyped embryos.
P < 0.0001, Student’s t-test.
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either via Atr depletion or Atr inhibition (Fig. 5E and F and
Supplementary Material, Fig. S3C).
Finally, we assessed pancreas localization through WMISH
for insulin (Fig. 5G). This analysis demonstrated that embryos
lacking functional Atr following depletion or kinase inhibition
also experienced randomization of other abdominal organs as
the pancreas was often located on the wrong side of the embryo
(Fig. 5H and I and Supplementary Material, Fig. S3D).
These assays raise the possibility that Atr functions directly
on or in cilia. We hypothesized that depletion of Atr speciﬁcally
within the ciliated KV cellswould lead to randomization of asym-
metry development as the KV functions as a temporal left-right
organizer. Consistent with this, we observed that atrmRNA is ex-
pressed in the tailbud region of zebraﬁsh embryos at a time and
position where the KV is found (Fig. 5J). Injection of Atr MO at the
1k cell stage to target the MO to the KV effectively interfered with
normal heart looping (Fig. 5K). Collectively, these results reveal
an important function of Atr in cilia biology.
ATR is required for SMO localization in cilia
The ﬁndingsmentioned earlier provide strong evidence that ATR
deﬁciency has a small impact on cilia length, but a strong impact
on cilia signalling and function during development. Finally, we
aimed to gain insight into how ATR affects cilia function. To
examine steps during Shh signalling, we used SAG, a direct agon-
ist of SMO.When cells are treated with SAG, SMO accumulates in
the cilium (48,49). As ATR depletion did not dramatically impact
upon cilia formation,we examinedwhether it affected SMOaccu-
mulation in cilia in the presence of SAG. At 72 h after serum star-
vation without SAG, we observed that ∼80% of the control
ﬁbroblasts formed cilia (Fig. 6A) with SMO localized in a diffuse
pannuclearmanner (Fig. 6B). Addition of SAG for theﬁnal 24 h re-
sulted in SMO concentration at the cilia, with ∼50% of the control
cells showing co-localized acetylated tubulin and SMO (Fig. 6C).
PCNT ﬁbroblasts formed cilia at a level similar to control cells,
but co-localization of SMO and acetylated tubulin was reduced
Figure 4.Morphological changes caused by Atr depletion in zebraﬁsh. (A) Live images of 48 hpf zebraﬁsh embryos. As controls, zebraﬁshwere either left uninjected (NI) or
control injected (CTRL) with a standard control MO (CTRL MO) or a 5 base mismatch MO (splCTRL MO), respectively. To generate Atr loss of function, injections with a
translation blocking MO against Atr (Atr MO) or an MO interfering with Atr splicing (Atr splMO) were performed. Scale bars: 500 µm. (B) The percentage of embryos
with an underdeveloped head. Graph displays mean values ± SEM, and n = 111–193 embryos in 5–11 experiments. ****P < 0.0001, one-way ANOVA. (C) Loss of Atr
interferes with regular eye development. Graph displays means ± SEM, and n = 93–113 embryos in 5–11 experiments. ****P < 0.0001, one-way ANOVA. (D) Representative
images of RT–PCR experiments assessing splice blocking efﬁciency of Atr splMO compared with controls. Left panel shows PCR of exons 2–4 of atr with a weaker band
at the expected size and an additional smaller band representing the mis-spliced product upon Atr splMO injection. Right panel shows a PCR fragment of βActin as
loading control. (E) Live images of zebraﬁsh embryos (48 hpf) treated with either 1% DMSO or 10 µ Atr inhibitor (ATRi-1) from the tailbud stage on. Scale bars:
500 µm. (F) Inhibition of Atr by chemical means (ATRi-1) results in a similar reduction of the head size of 48 hpf embryos. Graph displays mean values ± SEM, and
n = 95–217 embryos in ﬁve experiments. P < 0.0001, Student’s t-test. (G) The percentage of embryos developing smaller eyes upon Atr inhibition. Results show the
mean values ± SEM, and n = 95–217 embryos in ﬁve experiments. P < 0.0001, Student’s t-test.
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and/or abnormal (Fig. 6A–D). Strikingly, ATR-SS cells showed al-
most no localization of SMO at the cilia either with or without
SAG (Fig. 6E). Additionally, we observed that a subset of ATR-SS
cells showed disordered staining and localization of acetyl tubu-
lin following SAG addition (Fig. 6B). In summary, although SMO
localized at the cilia in PCNT cells, it was frequently abnormal;
in contrast, ATR-SS cells showed almost no SMO localization at
the cilia, suggesting that Shh signalling depends on ATR-
mediated translocation of SMO to the cilium. To substantiate a
causal relationship, we veriﬁed that the defect in SMO localiza-
tion could be complemented by ATR cDNA. Following transfec-
tion of ATR-SS cells with ATR cDNA, we observed substantial
recovery of SMO localization to cilia (Fig. 6E). The partial recovery
is likely due to the fact that only∼50% of the hTERT immortalized
ﬁbroblasts undergo transfection. Nonetheless, the substantial re-
covery strongly argues that the defect is caused by defective ATR.
ATR impact on SMO localization is replication-
independent
Finally, we exploited the dependency of SMO localization in cilia
onATR to gain insight intowhether ATR’s role in cilia signalling is
a downstream consequence of its role in promoting replication
fork recovery or whether it can be uncoupled from ATR’s
Figure 5. Loss of Atr impairs cilia function in zebraﬁsh. (A) WMISH of 22 ss embryos illustrating southpaw (spaw) expression in the left lateral plate mesoderm (left panel).
Ambiguous (middle panel) or right-sided expression (right panel) indicates aberrant left-right asymmetry. Scale bar: 200 µm. (B) Percentage of embryoswith left-sided (L),
right-sided (R), ambiguous (B) or no spaw expression upon Atr MO. n= 93–125 embryos; four experiments. P < 0.0001. (C) Chemical inhibition of Atr (ATRi-1) randomizes
spaw expression. n = 124–197 embryos; six experiments. P < 0.0001. (D) Representative images of WMISH for cardiac myosin light chain 2 (cmlc2) showing heart looping in
48 hpf embryos. Left panel, a correctly looped heart (D-loop); middle panel, a heart with no looping (no loop); right panel, an inversely looped heart (L-loop). A,
atrium; V, ventricle. Scale bar: 100 µm. (E) Atr depletion impedes heart looping (48 hpf). Stacked bar graph displaying the percentage of embryos with a properly
looped heart (D), an unlooped heart (N) or an inversely looped heart (L). n = 94–108; four experiments. P < 0.0001. (F) ATRi-1 inhibitor treatment randomizes cardiac
looping similar to that observed in knockdown embryos. n = 106–243; seven experiments. P = 0.009. (G) WMISH for insulin (ins) labelling of pancreatic cells to assess
abdominal situs development. Left panel, a dorsal view of a control. The ins expression domain is right of the midline (dashed line). Right panel, pancreas located left
of the midline. Embryos were 48 hpf. Scale bar: 200 µm. (H) Stacked bar graph summarizing correct (R) or wrong-sided (L) expression of ins in injected embryos. n = 94–
105 embryos; four experiments. P = 0.001. (I) Aberrant pancreas placement after Atr depletion (48 hpf). n = 118–245 embryos; seven experiments. P = 0.008. (J) Flat
mounts of four and eight ss embryos after WMISH for Atr. Note the stronger staining and higher Atr expression in the tailbud region, where the KV forms. Anterior to
the left. Scale bars: 150 µm (four ss) and 200 µm (eight ss). (K) KV-speciﬁc Atr knockdown randomizes cardiac looping. Stacked bar graph of embryos processed for
cmlc2WMISH. n = 66–67 embryos; three experiments. P < 0.0001. Signiﬁcance was assessed using Fisher’s exact test.
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canonical function during replication. To achieve this, we
exploited another ATR-speciﬁc small molecular inhibitor that
we have found works efﬁciently in human cells (data not
shown) (ATRi:VE) to examinewhether ATR’s kinase activity is re-
quired for SMO localization in cilia and whether ATR’s function
necessitates ATR activity during replication. Two protocols
were assessed (Fig. 7A). In the ﬁrst, cells were allowed to enter
G0 phase by serum starvation for 48 h in the presence of ATRi:
VE and then SAG was added for 24 h (maintaining ATRi:VE
addition) prior to the analysis of SMO localization (termed long-
term ATRi:VE). In the second protocol (termed short-term ATRi:
VE), cells were serum-starved for 48 h and then ATRi:VE and
SAG added for 24 h prior to the analysis of SMO localization. In
the ﬁrst protocol, the completion of replication and entry into
G0 phase occurred under the condition of ATR inhibition; in the
second protocol, ATR was only inhibited during cilia formation
once a non-replicating state had been reached. In control cells
(CTRL), SAG addition resulted in ∼45% of the cilia showing SMO
Figure 6. ATR-SS cells show defects in SMO recruitment to cilia and GLI1 transcript activation. Patient-derived hTERT ﬁbroblasts were serum-depleted for 48 h. SAG was
then added for 24 h. (A) Under this prolonged condition of serum starvation (72 h), cilia form normally in all cell lines. (B) In control cells, in the absence of SAG, SMO
localized diffusely and not speciﬁcally at cilia. In the presence of SAG, strong uniform SMO staining is observed along the cilia length (detected using acetylated
tubulin). (C) The percentage of cells with co-localized cilia and SMO with or without SAG treatment. (D) The percentage of ciliated cells with abnormally localized
SMO with or without SAG treatment. (E) SMO localization at cilia in ATR-SS cells can be restored following expression of ATR cDNA but not kinase dead ATR cDNA
(KD). Results represent the mean ± SD of three experiments. WT and PCNT data are part of the data set previously published in Stiff et al. (16).
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localization (Fig. 7B). Addition of ATRi:VE during cell cycle exit
and SAG addition (ATRi-VE long time) reduced the percentage
of cilia with SMO localization to ∼2% (Fig. 7B). Signiﬁcantly, add-
ition of ATRi:VE after cell cycle exit (ATRi-VE short time) also re-
sulted in a marked defect in cilia with co-localized SMO (∼10%)
(Fig. 7B). Although this is slightly higher than when ATRi:VE
was added throughout the period, the ﬁndings nonetheless pro-
vide strong evidence that ATR inhibition after cells have exited
the cell cycle can markedly reduce SMO localization, strongly
suggesting that ATR’s function is distinct to its direct impact on
replication. To consolidate this, we also added ATRi:VE for 2
days during the cycling period; then upon serum withdrawal
and during subsequent SAG addition, ATRi:VE was removed
(Fig. 7A). Normal localization of SMO was observed (Fig. 7B).
To further examine the requirement for additional factors
during ATR-dependent cilia signalling, we examined the role of
CHK1, which plays a critical role in ATR-dependent responses
at the replication fork. In marked contrast to the addition of
ATRi, addition of a CHK1 inhibitor (CHK1i) using the long-term
protocol (i.e. from the point of serum starvation to analysis) did
not affect SMO localization (Fig. 7B). Our previous analysis has
shown that such treatment dramatically impairs other ATR-de-
pendent endpoints such as G2/M checkpoint arrest (50). As ATR
has a role at the centrosome via directly or indirectly phosphor-
ylating Aurora A kinase or Polo kinase I (PLK1), we also added in-
hibitors for these two kinases (AurAi or Plki) using the long-term
protocol (at the start of serum starvation) and observed normal
SMO localization in the presence of SAG (Fig. 7B) (51,52). Thus,
ATR function in cilia signalling does not operate via any regula-
tion of Aurora A kinase or PLK1 kinase activities.
A recent study has shown that ATR can be activated at the nu-
clear envelope by mechanical stress in a manner independent of
DNA damage and RPA, the single-strand DNA binding protein re-
quired for ATR activation during replication (53,54). To test
whether RPA is required for SMO localization, we depleted RPA
by siRNA knockdown of the RPA-70 subunit in hTERT cells ap-
proaching conﬂuency. This procedure allowed efﬁcient knock-
down of RPA in G0 phase cells without causing signiﬁcant cell
death. Interestingly, G0 phase cells had reduced RPA levels
when compared with cycling cells, but RPA-70 siRNA resulted
in a further reduction in RPA levels (Supplementary Material,
Fig. S4A). SMO localization occurred normally in these cells, con-
solidating the notion that ATR’s role in cilia function can be un-
coupled from its function during replication (Supplementary
Material, Fig. S4B). Finally, ATR signalling is known to require
TOPBP1, which enhances ATR activation (55). Thus, we asked
whether cilia signalling also requires TOPBP1. Strikingly, and in
contrast to CHK1 inhibition, TOPBP1 siRNA conferred a defect in
SMO localization similar to that observed in ATR siRNA cells
(Fig. 7C). Collectively, these ﬁndings provide strong evidence
that the role of ATR in cilia signalling is not a downstream conse-
quence of its role in replication fork stability. Indeed, ATR inhib-
ition after cell cycle exit has a marked impact on SMO
localization. Further, CHK1, a transducer kinase for ATR DNA
damage signalling, which is required for ATR’s role in S phase,
is dispensable for cilia signalling. RPA similarly appears to be
Figure 7.Deﬁciency inTOPBP1 butnot inhibition of CHK1, PLK1orAuroraA also causesdefective cilia signalling. (A) Diagramshowing the timing ofATRi:VE addition, serum
withdrawal and SAG addition. (B) Control cells were treatedwith an ATR inhibitor (ATRi:VE) concurrentwith serumdeprivation for 72 h (long time) or deprived of serum for
48 handATRi:VE added for 24 h (short time). In both cases, SAGwas added for theﬁnal 24 h. Thepercentageof cellswith SMO localizedat ciliawas scored. Control cellswere
similarly treatedwith inhibitors against CHK1 (UCN01), AuroraA (AurAi) or PLK1 (Plk1i), concurrentwith serumdeprivation. For ATRi:VEwhencycling, cellswere treated for
48 hwith theATRi:VE before itwaswashed out and cells deprivedof serum for 72 has before,with SAGbeing added for theﬁnal 24 h. The results represent themean± SDof
three experiments. Note that analysis of cells without SAGwas not undertaken for the inhibitor experiments, as we had routinely observed that the absence of SAG led to
very low numbers of cells with SMO localized at the cilia. (C) 1BR3 hTERT cells were treated with oligonucleotides directed against non-speciﬁc control sequences (C), ATR
(siATR) or TOPBP1 (siTOPBP1). SAG was added for the ﬁnal 24 h, and the percentage of cells with SMO localized at the cilia was scored as in (B).
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dispensable for ATR’s role in cilia signalling. In marked contrast,
TOPBP1, which facilitates ATR activation, is required for SMO re-
cruitment to cilia, consistent with the requirement for ATR ki-
nase activity.
Discussion
ATR has a canonical function in the DDRwith an essential role in
promoting recovery from stalled/collapsed replication forks. Mu-
tations in ATR have been identiﬁed in a subclass of SS patients,
with microcephaly and severe growth delay being the pro-
nounced phenotypes. These clinical manifestations have been
attributed to the canonical function of ATR in regulating the
DDR during replication (2,6). Although this is a plausible model,
other disorders with associated microcephaly and growth delay
havemutations in genes required for centrosome function rather
than for the DDR/replication (7). Provocatively, we previously re-
ported that ATR-SS cells have supernumerary centrosomes. Pre-
vious studies have demonstrated a link between abnormal
centrosomenumbers and cilia dysfunction (13,15,27). These ﬁnd-
ings prompted us to examine whether ATR might also be re-
quired for cilia signalling. Here, we provide strong evidence that
depletion or inhibition of ATR in human cells results in a subtle
defect in cilia length and a more pronounced defect in cilia sig-
nalling, including Shh signalling. We demonstrate that this role
of ATR is conserved in zebraﬁsh and use this model organism
to probe for a functional impact. Strikingly, zebraﬁsh depleted
for Atr display typical defects in morphology and lateralization
determination, similar to that found following depletion of sev-
eral other factors required for cilia formation or signalling. Col-
lectively, these ﬁndings provide strong evidence that ATR is
required for efﬁcient cilia function during development.
Signiﬁcantly, ATR deﬁciency in patients confers marked
microcephaly, reﬂecting a role for ATR during neuronal embryo-
genesis, and additional abnormalities in growth and skeletogen-
esis (2,56). The link between centrosomal function and MPD
disorders has been previously highlighted (11,12). Many proteins
with centrosomal functions are causal for MPD disorders (7). Of
these disorders, MOPD-II andMGS also have aberrant cilia signal-
ling. Further, a recent study also showed that mutations in
MRE11, ZNF423 and CEP164, genes which encode proteins that
function within the DDR, can cause nephronophthisis, providing
another link betweenDDR signalling and ciliopathies (57). Recent
patients with mutations in MRE11 have also been reported to
have microcephaly (58). Additionally, chondrogenesis involves
cilia-dependent signalling (59), and ATR-SS patients and mouse
models of impaired Atr function have skeletal abnormalities (6).
Interestingly, one subclass of Jeune asphyxiating thoracic dys-
trophy patients with the same missense mutation in CEP120, a
centriolar protein, have a range of skeletal abnormalities (60).
The patient cells display centriole abnormalities and reduced
cilia formation. For ATR deﬁciency, it could be the role in cilia sig-
nalling rather than, or in addition to, its canonical function inDDR
signalling that confers the clinical manifestation. Importantly,
embryonicneuronal development involves Shh signalling (24–26).
A marked phenotype of impaired cilia function in zebraﬁsh is
a left-right patterning defect. Strikingly, this phenotype is also
observed following depletion of Atr in zebraﬁsh, in which we de-
tected asymmetry defects at different stages and in different or-
gans. These phenotypes, however, have not been described as
marked features of the ATR-deﬁcient patients described to date.
Furthermore, although PCNT and ORC1 deﬁciency also confer
signiﬁcant defects in cilia signalling, ATR-SS, MOPD-II nor MGS
patients show the commonly described manifestations of
defective ciliogenesis (e.g. renal cystic disease). However, themu-
tations in all of these patients are hypomorphic asATR, PCNT and
ORC1 are essential and in each case the mutations must allow
sufﬁcient residual protein function to enable embryogenesis
and patient viability. Further, ciliopathies are clinically heteroge-
neous and cilia dysfunction manifests in distinct ways. In this
context, we note that ATR-, PCNT- and ORC1-deﬁcient patients
display skeletal abnormalities, and there is mounting evidence
that cilia function during skeletogenesis, and at least one ATR-
SS patient, has been describedwithmultiple liver cysts indicative
of Caroli’s disease (56). Furthermore, we note that ATR deﬁciency
was recently reported to cause retinal photoreceptor degener-
ation in mice, a process linked to cilia dysfunction (61).
A role in cilia function represents a novel role for ATR. Further,
we provide evidence that this is distinct to ATR’s canonical role in
recovery from replication fork stalling as diminished cilia signal-
ling is observed when ATR is inhibited after the cessation of rep-
licationandas theprocess is not dependent onCHK1, an essential
protein required for recovery from replication fork stalling. Our
ﬁndings, moreover, cannot readily be attributed to any changes
in growth rate. However, ATR’s role in cilia signalling does require
its kinase activity as well as TOPBP1, a protein that promotes
ATR’s ability to phosphorylate its substrates. Although it is difﬁ-
cult to entirely separate ATR’s role as a DDR protein from its func-
tion in cilia signalling, the latter function does not necessitate
treatment with exogenous DNA-damaging agents. However,
whether DNA damage arises during cilia formation is unknown.
Our study, therefore, raises the question of the basis under-
lying the role of ATR in cilia signalling. Although centrosomes
are required for ciliogenesis, the cilia defect need not be a direct
consequence of impaired centrosome function but may reﬂect
dual roles for the proteins (27). Nonetheless, ATR does have a
function at the centrosome, where it can regulate the phosphor-
ylation of the kinases, PLK1 and Aurora A, albeit in a damage-
dependent manner (51,52,62). We tentatively propose, therefore,
that ATR can be activated in a manner that does not require ex-
ogenousDNAdamage or replication-dependent damage at either
the centrosome or the cilia. In this context, a signiﬁcant recent
study showed thatATRcould be activated at the nuclear envelope
by forces such asmechanical stretching (53). Indeed, the ﬁndings
strongly suggested that signals from the cell membrane could be
transmitted to the nuclear membrane. The formation of cilia is
likely to impose such a force, providing a route to activate ATR.
ATR has multiple substrates that could impact upon cilia signal-
ling. However, further studies are required to untangle the pre-
cise mechanism.
In summary,we demonstrate a novel function for ATR in cilia-
dependent signalling in both human cells and zebraﬁsh. Our
ﬁndings provocatively raise the possibility that ATR-SS may re-
present a ciliopathy disorder and that impaired cilia function
may contribute to their clinical manifestation.
Materials and Methods
Cell culture
hTERT-immortalized ﬁbroblasts were control (1BR3hTERT), ATR
(FO2-98hTERT), ATM (AT1BRhTERT) and PCNT (ASBhTERT).
siRNAwas carried out using the appropriate Smartpool (Dharma-
con, Lafayette, CO, USA) and Metafectene Transfection Reagent
(Biontex, Munich, Germany). The ATR inhibitor, VE-821 (Selleck-
chem/Stratech, Newmarket, UK), was used at 10 µ. The Aurora
A kinase inhibitor, MLN8237 (Selleckchem/Stratech), was used
at 0.5 µ. The Polo-like kinase 1 inhibitor, BI2536 (Axon
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Medchem, Groningen, TheNetherlands), was used at 100 n. The
Chk1 inhibitor, UCN-01 (Merck, Kenilworth, NJ, USA), was used at
600 n.
Zebraﬁsh manipulation
Zebraﬁsh eggs were collected from natural matings and were
allowed to develop up to the desired stages at 28.5°C. For knock-
down studies, fertilized eggs were injected in the yolk at the 1–2
cell stage or the 1000 cell stage to target dorsal forerunner cells.
Antisense MOs used were the standard control MO and a trans-
lation blocking MO for Atr, which had been described before
(41). In addition, MOs targeting the boundary of intron 2 and
exon 3 (Atr splMO: 5′-CAGAGCAACTACAATGTGATAGAGA) and
a corresponding 5 bpmismatch control MO (splCTRLMO: CAcAc-
CAAgTACAATcTcATAGAGA) were used. All MOs were purchased
from Gene Tools Inc. (Philomath). Rescue experiments were per-
formed by co-injection of capped RNA encoding human ATR and
a kinase dead version of human ATR (p.D2494E), respectively
(plasmids were a gift from Dr A.M. Carr). Capped RNA was
prepared with the T7 mMessage mMachine Kit (Ambion) using
linearized plasmids. Drug treatment with either dimethyl sulph-
oxide (DMSO) (Sigma-Aldrich, St Louis, MO, USA) or the ATR
Kinase Inhibitor III (CAS 1345675-02-7 Calbiochem/EMD Milli-
pore, Watford, UK) was performed in egg water from tailbud
stage on. All procedures on zebraﬁsh adhered to current law
and were approved by the local authority in Ulm, Germany.
Splice blocking efﬁciency test (RT–PCR)
Splice blocking efﬁciency was tested using RT–PCR on RNA pre-
pared from 24 h post fertilization (hpf ) embryos with primers
spanning over exon 3: Atr Fw: 5′-GGTTGAGTACAACCAGGCAGT;
Atr Rev: 5′-AACAGGCTAAACACGACTGGA. This produces a
378 bp fragment under control conditions. When splicing is
blocked and exon 3 is deleted, a PCR product of 225 bp is expected.
To control for loading, a PCR for β-actin was performed with the
following primers: β-actin Fw: 5′-GACATCAAGGAGAAGCTGTGC;
β-actin Rev: 5′-CACTTCCTGTGAACGATGGAT.
IF analysis
Cells grown on cover slips were ﬁxed with 3% formaldehyde for
7 min and then with ice cold 70% MeOH for 1 min and permeabi-
lized in 0.5% Triton X-100. For BrdU staining, DNAwas denatured
in 2 N HCl for 30 min. After antibody treatment and staining with
4,6-diamidino-2-phenylindole, cover slips were mounted in Vec-
tashield mounting medium (Vector Laboratories, Burlingame,
CA, USA). Samples were incubated with primary antibodies for
BrdU (BU20A), CenPF, PCNT, phospho-H3 (Santa Cruz, Santa
Cruz, CA, USA), γ-tubulin, acetylated tubulin (Sigma, St Louis,
MO, USA), phospho-Rb (Cell Signaling, Beverley, MA, USA) and
Smoothened (Abcam, Cambridge, UK). Secondary antibodies
were from Sigma.
Fibroblasts were grown to 70–80% conﬂuency followed by
serum starvation in MEM containing 0.1% fetal calf serum (FCS)
for 2–3 days to promote entry into G0. Cells were processed for
IF as mentioned earlier and cilia visualized with anti-acetylated
tubulin and γ-tubulin antibodies.
Shh pathway assay
Fibroblasts were serum-starved for 2–3 days in MEM containing
0.1% FCS. An aliquot of 1 µ SAG (Smoothened Agonist, Calbio-
chem, Billerica, MA, USA) was added for a further 24 h. Cells
were processed for IF as above. Cilia or the basal body was iden-
tiﬁed by antibodies against acetylated tubulin and γ-tubulin and
then Smoothened staining at the cilium was assessed.
Cilia function assay
Fibroblasts were serum-starved for 2–3 days in MEM containing
0.1% FCS. Then MEM with FCS or with 50 ng/ml PDGF-AA,
PDGF-AB or PDGF-BB (Sigma) was added. S phase cells were iden-
tiﬁed by labelling with 10 µ BrdU (Becton Dickinson, Franklin
Lakes, NJ, USA) and processed for IF as mentioned earlier.
siRNA knockdown
The protocol for siRNA-mediated knockdown of PCNT and ATR
was as described previously (8,63). These references include an
analysis of knockdown efﬁciency using an identical procedure,
and a similar level of knockdown was obtained in this study.
RPA knockdown of RPA-70 was achieved using an RNAi SMART-
pool from Dharmacon. Knockdown efﬁciency for RPA-70 was as-
sessed by western blot using mouse-anti-RPA (Calbiochem cat.
no. NA13) and mouse-anti-β-actin (Abcam cat. no. Ab40864).
qPCR analysis
qRT–PCR for Smoothened and Gli1 analysis was carried out using
the QuantiFast SYBR Green PCR Kit (Qiagen, Venlo, The Nether-
lands). SDHA was used for internal normalization, and the Pfafﬂ
analysis method was applied. The primer sets used were Qiagen
Quantitect primers for SMO and SDHA (QT00050701 and
QT00059486) and for GLI1: (F) CCAGCCAGAGAGACCAACA and
(R) ATCCGACAGAGGTGAGATGG. In brief, reactions containing
12.5 µl SYBR Green PCR Master Mix (Qiagen), 2.5 µl 10× Primer
assay mix, 5 µl RNAse-free water and 5 µl template cDNA to a
ﬁnal volume of 25 µl were prepared in duplicate. Cycling was car-
ried out using the StratageneMx3005PQPCR System. Cycling con-
ditions were: 95°C for 5 min, followed by 40 cycles of 95°C for 10 s
and 60°C for 30 s. Reactions were then heated to 95°C for 1 min
and incubated at 55°C for 30 s.
qPCR analysis of zebraﬁsh was performed as described previ-
ously (45) using the Absolute qPCR ROX Mix (Thermo Scientiﬁc,
UK) and the Roche Universal Probe System (Roche Applied
Science, Mannheim, Germany) in a Lightcycler 480 instrument
(Roche). All levels were normalized to beta-2-microglobulin (b2m)
(GenBank no. BC062841.1). The following primers and probes
(UP) were used: gli1 Fw: 5′-GGTCTCGATGCCAGTGGA, gli1 Rev:
5′-CACTGACGGAGCCAGTCC, UP no. 5; puma Fw: 5′-CGAGAT
GAACGCTGTCTTCC, puma Rev: 5′-CCTCTCCAGTTCTGCCAGTG,
UP no. 6; p21 Fw: 5′-AAGCGCAAACAGACCAACAT, p21 Rev:
5′-TCAGCTACTGGCCGGATTT, UP no. 142; b2m Fw: 5′-ACATC
ACTGTACAGGGGAAAGTC, b2m Rev: 5′-TCCGTTCTTCAGCAG
TTCAA, UP no. 65.
Centrosome analysis
Cycling ﬁbroblastswere processed for IF asmentioned earlier and
centrosomes visualized with anti-γ-tubulin and PCNT antibodies.
Microscopy
Living zebraﬁsh and those processed by WMISH were imaged
using a Leica M125 upright microscope equipped with a Leica
IC80 HD camera. KVs and cilia were assessed by confocal micros-
copy with a Leica TCS SP5II confocal microscope. Cilia length in
z-stacks was measured with the help of ImageJ (64).
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WMISH
WMISH was performed according to standard protocols (65). The
DIG-labelled probes for cmlc2, ins and spaw have been described
before (45). The probe for atr was generated by in vitro transcrip-
tion from a linearized plasmid containing a 1001 bp fragment of
the Atr coding sequence (GenBank no. XM_691071).
IF analysis for zebraﬁsh work
IF analysis was as described earlier. Zebraﬁsh cilia were labelled
according to the protocol of Jaffe et al. (66) using a mouse-anti-
acetylated tubulin antibody (1:500, clone 6-11B-1, Sigma-Aldrich)
and an Alexa 488-labelled secondary antibody. KV outlines were
visualized through immunostaining with an antibody against
atypical PKC (1:500, clone C-20, Santa Cruz Biotechnologies).
Statistical analysis
All statistical analysis was performed using GraphPad Prism
6. When three conditions were analysed, a one-way analysis of
variance with a Bonferroni post-test was applied. Analyses in-
cluding only two experimental conditions (i.e. DMSO versus
Atri) were scrutinized with one- or two-tailed Student’s t-tests.
Stacked bar graphs were tested for statistical signiﬁcance using
a Fisher’s exact test.
Supplementary Material
Supplementary Material is available at HMG online.
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